New research shows that Ozempic and similar drugs reduce opioid overdoses by 40% and alcohol intoxication by 50% in people ...

Only 15% of those who start a glucagon-like peptide 1 (GLP-1) for weight loss are still taking it two years according to ...

GLP-1 receptor agonists and similar drugs may protect people with opioid or alcohol use disorder from opioid overdose and ...

Response Pharmaceuticals has initiated subject enrolment for a Phase II trial of its drug candidate RDX-002, designed to ...

Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have comorbid type 2 diabetes, high body mass index, and a previous metformin ...

Newer weight loss drugs are cost effective in the long term only when combined with bariatric weight loss surgery, according ...

A new study reveals that glucagon-like peptide-1 receptor agonists (GLP-1), which include weight loss and diabetes med ...

Both Wegovy and Mounjaro are given as weekly injections via pre-filled pens that can be self-administered into the upper arm, ...

Obese teens who have been prescribed popular weight loss drugs like Ozempic, Wegovy, and Mounjaro may be less likely to have ...

The FDA has already made more than a dozen cancer drug approval decisions this year and more expected in the next several ...

Ozempic and other semaglutide medications for weight loss have been linked to hair loss on social media. Experts share who is ...

Have you finally decided to explore treatment plans for weight loss or erectile dysfunction? Are you finding that ...